Pharmacy First prescribing expanded to ease GP pressure
From the autumn, pharmacists in England will be able to prescribe a wider array of medicines under the Pharmacy First programme.
Newsletters and Deep Dive digital magazine
From the autumn, pharmacists in England will be able to prescribe a wider array of medicines under the Pharmacy First programme.
AstraZeneca has claimed another key FDA approval for Imfinzi in bladder cancer, as an add-on to BCG therapy for early non-muscle invasive disease.
France's Health Minister has said that the country is the first in the EU to provide reimbursement coverage for GLP-1 weight-loss therapies.
The FDA has started a priority review of Sanofi's brain-acting Gaucher disease therapy venglustat, with an action date of 25th November.
AbbVie's Decnupaz approval will give patients with rare blood cancer BPDCN an alternative to Stemline's Elzonris with a simpler dosing regimen.
Editor's Picks
Newsletters and Deep Dive
digital magazine